AU2001238472A1 - Method for treating parathyroid disorders - Google Patents
Method for treating parathyroid disordersInfo
- Publication number
- AU2001238472A1 AU2001238472A1 AU2001238472A AU3847201A AU2001238472A1 AU 2001238472 A1 AU2001238472 A1 AU 2001238472A1 AU 2001238472 A AU2001238472 A AU 2001238472A AU 3847201 A AU3847201 A AU 3847201A AU 2001238472 A1 AU2001238472 A1 AU 2001238472A1
- Authority
- AU
- Australia
- Prior art keywords
- parathyroid disorders
- treating
- treating parathyroid
- disorders
- parathyroid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
- A61K38/4893—Botulinum neurotoxin (3.4.24.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
- A61P5/20—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of PTH
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51071100A | 2000-02-22 | 2000-02-22 | |
US09510711 | 2000-02-22 | ||
PCT/US2001/005206 WO2001062269A2 (en) | 2000-02-22 | 2001-02-16 | Use of neurotoxins for treating parathyroid disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001238472A1 true AU2001238472A1 (en) | 2001-09-03 |
Family
ID=24031856
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001238472A Abandoned AU2001238472A1 (en) | 2000-02-22 | 2001-02-16 | Method for treating parathyroid disorders |
Country Status (5)
Country | Link |
---|---|
US (5) | US6328977B1 (en) |
AR (1) | AR030406A1 (en) |
AU (1) | AU2001238472A1 (en) |
TW (1) | TWI284536B (en) |
WO (1) | WO2001062269A2 (en) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6524580B1 (en) * | 2000-02-15 | 2003-02-25 | Allergan Sales, Inc. | Method for treating thyroid disorders |
US20040170665A1 (en) * | 2000-06-02 | 2004-09-02 | Allergan, Inc. | Intravitreal botulinum toxin implant |
US20040033241A1 (en) * | 2000-06-02 | 2004-02-19 | Allergan, Inc. | Controlled release botulinum toxin system |
US6903187B1 (en) * | 2000-07-21 | 2005-06-07 | Allergan, Inc. | Leucine-based motif and clostridial neurotoxins |
US20040219619A1 (en) * | 2000-07-21 | 2004-11-04 | Ester Fernandez-Salas | Methods of identifying compounds that alter toxin persistence and/or protease activity |
US7491799B2 (en) * | 2000-07-21 | 2009-02-17 | Allergan, Inc. | Modified botulinum neurotoxins |
US7691983B2 (en) * | 2000-07-21 | 2010-04-06 | Allergan, Inc. | Chimera botulinum toxin type E |
JP4707254B2 (en) * | 2001-04-24 | 2011-06-22 | クミアイ化学工業株式会社 | Granular composition and method for producing the same |
KR20030018827A (en) * | 2001-08-31 | 2003-03-06 | 서구일 | Sympathetic nerve bl0cking agent comprising botulinum toxin type a, and composition for treatment of the sympathetic nerve related diseases |
US7238357B2 (en) * | 2002-11-05 | 2007-07-03 | Allergan, Inc. | Methods for treating ulcers and gastroesophageal reflux disease |
US20040086532A1 (en) * | 2002-11-05 | 2004-05-06 | Allergan, Inc., | Botulinum toxin formulations for oral administration |
KR20050109969A (en) * | 2003-03-06 | 2005-11-22 | 보툴리늄 톡신 리서치 어쏘시에이츠, 인크. | Treatment of sinusitis related chronic facial pain and headache with botulinum toxin |
WO2004078200A1 (en) * | 2003-03-06 | 2004-09-16 | Botulinum Toxin Research Associates, Inc. | Selection of patients with increased responsiveness to botulinum toxin |
US7396535B2 (en) * | 2003-04-25 | 2008-07-08 | Ackerman Alan H | Therapy for obsessive compulsive head banging |
US7393538B2 (en) * | 2003-04-25 | 2008-07-01 | Ackerman Alan H | Clostridial toxin treatment for dermatillomania |
US7390496B2 (en) * | 2003-04-25 | 2008-06-24 | Allergan, Inc. | Therapeutic treatments for repetitive hand washing |
US7393537B2 (en) * | 2003-04-25 | 2008-07-01 | Allergan, Inc. | Botulinum toxin for treatment of obsessive compulsive finger biting disorder |
US7422753B2 (en) * | 2003-04-25 | 2008-09-09 | Allergan, Inc. | Methods for treating trichotillomania |
US6838434B2 (en) * | 2003-05-02 | 2005-01-04 | Allergan, Inc. | Methods for treating sinus headache |
US20040226556A1 (en) | 2003-05-13 | 2004-11-18 | Deem Mark E. | Apparatus for treating asthma using neurotoxin |
US7220422B2 (en) * | 2003-05-20 | 2007-05-22 | Allergan, Inc. | Methods and compositions for treating eye disorders |
US20040253274A1 (en) * | 2003-06-11 | 2004-12-16 | Allergan, Inc. | Use of a clostridial toxin to reduce appetite |
US20050013850A1 (en) * | 2003-07-15 | 2005-01-20 | Caers Jan K. | Device to assist hyperhydrosis therapy |
US7318925B2 (en) * | 2003-08-08 | 2008-01-15 | Amgen Fremont, Inc. | Methods of use for antibodies against parathyroid hormone |
AU2003282780A1 (en) | 2003-08-08 | 2005-03-07 | Abgenix, Inc. | Antibodies directed to parathyroid hormone (pth) and uses thereof |
US8617572B2 (en) * | 2003-10-29 | 2013-12-31 | Allergan, Inc. | Botulinum toxin treatments of depression |
US8734810B2 (en) | 2003-10-29 | 2014-05-27 | Allergan, Inc. | Botulinum toxin treatments of neurological and neuropsychiatric disorders |
US8609112B2 (en) | 2003-10-29 | 2013-12-17 | Allergan, Inc. | Botulinum toxin treatments of depression |
US8609113B2 (en) | 2003-10-29 | 2013-12-17 | Allergan, Inc. | Botulinum toxin treatments of depression |
US7172764B2 (en) * | 2003-11-17 | 2007-02-06 | Allergan, Inc. | Rescue agents for treating botulinum toxin intoxications |
US20050129677A1 (en) * | 2003-12-10 | 2005-06-16 | Shengwen Li | Lipid rafts and clostridial toxins |
US20070264373A1 (en) * | 2004-01-26 | 2007-11-15 | Ian Carroll | Toxin Induced Sympathectomy |
US20060024794A1 (en) * | 2004-07-30 | 2006-02-02 | Shengwen Li | Novel methods for production of di-chain botulinum toxin |
GB0426397D0 (en) | 2004-12-01 | 2005-01-05 | Health Prot Agency | Fusion proteins |
EP1906923B1 (en) | 2005-07-22 | 2018-01-24 | The Foundry, LLC | Systems and methods for delivery of a therapeutic agent |
US10052465B2 (en) | 2005-07-22 | 2018-08-21 | The Foundry, Llc | Methods and systems for toxin delivery to the nasal cavity |
US9511210B2 (en) | 2006-05-19 | 2016-12-06 | The Foundry, Llc | Apparatus for toxin delivery to the nasal cavity |
US7910116B2 (en) * | 2005-08-24 | 2011-03-22 | Allergan, Inc. | Use of a botulinum toxin to improve gastric emptying and/or to treat GERD |
US7794386B2 (en) | 2006-03-15 | 2010-09-14 | Allergan, Inc. | Methods for facilitating weight loss |
US7811586B2 (en) * | 2006-05-02 | 2010-10-12 | Allergan, Inc. | Methods for alleviating testicular pain |
US20080092910A1 (en) * | 2006-10-18 | 2008-04-24 | Allergan, Inc. | Apparatus and method for treating obesity using neurotoxins in conjunction with bariatric procedures |
US20080113051A1 (en) * | 2006-11-13 | 2008-05-15 | Allergan, Inc. | Methods for alleviating tattoo pain |
US8483831B1 (en) | 2008-02-15 | 2013-07-09 | Holaira, Inc. | System and method for bronchial dilation |
US8470337B2 (en) * | 2008-03-13 | 2013-06-25 | Allergan, Inc. | Therapeutic treatments using botulinum neurotoxin |
EP4166107A1 (en) | 2008-05-09 | 2023-04-19 | Nuvaira, Inc. | Systems, assemblies, and methods for treating a bronchial tree |
EP4193948A1 (en) | 2009-10-27 | 2023-06-14 | Nuvaira, Inc. | Delivery devices with coolable energy emitting assemblies |
US8911439B2 (en) | 2009-11-11 | 2014-12-16 | Holaira, Inc. | Non-invasive and minimally invasive denervation methods and systems for performing the same |
US9149328B2 (en) | 2009-11-11 | 2015-10-06 | Holaira, Inc. | Systems, apparatuses, and methods for treating tissue and controlling stenosis |
KR20140054028A (en) | 2011-07-08 | 2014-05-08 | 알러간, 인코포레이티드 | Method for treatment of autonomic nervous system disorders |
US8992941B2 (en) | 2011-07-08 | 2015-03-31 | Allergan, Inc. | Method for treatment of esophageal spasm |
RU2578475C2 (en) | 2011-07-14 | 2016-03-27 | Аллерган, Инк. | Methods of treating incontinence associated with sexual activity |
BR112014001066A2 (en) | 2011-07-20 | 2017-02-21 | Allergan Inc | botulinum toxins for use in a method for treating adipose deposits |
US10035820B2 (en) | 2012-04-13 | 2018-07-31 | Lubrizol Advanced Materials, Inc | Compounds which inhibit neuronal exocytosis |
EP2649985A1 (en) | 2012-04-13 | 2013-10-16 | Lipotec, S.A. | Compounds which inhibit neuronal exocytosis (III) |
EP2649983A1 (en) | 2012-04-13 | 2013-10-16 | Lipotec, S.A. | Compounds which inhibit neuronal exocytosis (II) |
EP2649984A1 (en) | 2012-04-13 | 2013-10-16 | Lipotec, S.A. | Compounds which inhibit neuronal exocytosis |
US9398933B2 (en) | 2012-12-27 | 2016-07-26 | Holaira, Inc. | Methods for improving drug efficacy including a combination of drug administration and nerve modulation |
US10149893B2 (en) | 2013-09-24 | 2018-12-11 | Allergan, Inc. | Methods for modifying progression of osteoarthritis |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69312947T2 (en) | 1992-09-21 | 1998-01-08 | Pharmacia & Upjohn Company Kal | PROTEIN-BASED MEDICINES WITH DELAYED DELIVERY OF ACTIVE SUBSTANCES |
EP1013270A3 (en) | 1992-12-02 | 2001-03-28 | Alkermes Controlled Therapeutics, Inc. | Controlled release growth hormone containing microspheres |
GB9305735D0 (en) | 1993-03-19 | 1993-05-05 | North John R | Novel agent for controlling cell activity |
US5437291A (en) | 1993-08-26 | 1995-08-01 | Univ Johns Hopkins | Method for treating gastrointestinal muscle disorders and other smooth muscle dysfunction |
EP1147775B1 (en) * | 1993-12-28 | 2009-03-04 | Allergan, Inc. | Use of botulinum toxin type B for the manufacture of a medicament for reducing pain associated with a muscle disorder |
US5766605A (en) * | 1994-04-15 | 1998-06-16 | Mount Sinai School Of Medicine Of The City University Of New York | Treatment of autonomic nerve dysfunction with botulinum toxin |
US6007843A (en) | 1995-09-29 | 1999-12-28 | Lam Pharmaceuticals Corp. | Sustained release delivery system |
US5980945A (en) | 1996-01-16 | 1999-11-09 | Societe De Conseils De Recherches Et D'applications Scientifique S.A. | Sustained release drug formulations |
US6022554A (en) | 1997-12-15 | 2000-02-08 | American Home Products Corporation | Polymeric microporous film coated subcutaneous implant |
-
2000
- 2000-11-01 US US09/704,440 patent/US6328977B1/en not_active Expired - Fee Related
- 2000-11-01 US US09/704,441 patent/US6319506B1/en not_active Expired - Fee Related
- 2000-11-01 US US09/704,464 patent/US6649161B1/en not_active Expired - Fee Related
-
2001
- 2001-02-02 TW TW090102210A patent/TWI284536B/en not_active IP Right Cessation
- 2001-02-16 AU AU2001238472A patent/AU2001238472A1/en not_active Abandoned
- 2001-02-16 WO PCT/US2001/005206 patent/WO2001062269A2/en active Application Filing
- 2001-02-21 AR ARP010100784A patent/AR030406A1/en unknown
- 2001-04-16 US US09/835,949 patent/US6635247B2/en not_active Expired - Fee Related
- 2001-10-04 US US09/971,869 patent/US6974793B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20010023243A1 (en) | 2001-09-20 |
WO2001062269A2 (en) | 2001-08-30 |
US6319506B1 (en) | 2001-11-20 |
AR030406A1 (en) | 2003-08-20 |
US6974793B2 (en) | 2005-12-13 |
US6649161B1 (en) | 2003-11-18 |
US6635247B2 (en) | 2003-10-21 |
US6328977B1 (en) | 2001-12-11 |
WO2001062269A3 (en) | 2002-05-02 |
TWI284536B (en) | 2007-08-01 |
US20020018786A1 (en) | 2002-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001238472A1 (en) | Method for treating parathyroid disorders | |
AU2001238369A1 (en) | Method for treating thyroid disorders | |
AU2001285159A1 (en) | Methods for treating endocrine disorders | |
AU7085100A (en) | Method for treating otic disorders | |
AU2002215125A1 (en) | Well treatment method | |
AU2003299083A1 (en) | A method for treating severe tinnitus | |
AU2003216379A1 (en) | Method for treating otic disorders | |
AU2001231104A1 (en) | Methods for treating diabetes | |
EP1414464A4 (en) | Method for treating glaucoma v | |
AU2001269799A1 (en) | Methods for treating various eye disorders | |
AU2002225930A1 (en) | Methods for treating phosphatide-containing mixtures | |
AUPR617901A0 (en) | Method for treating multiple myeloma | |
AU3222801A (en) | Method for treating oil-containing sludge | |
MXPA03006607A (en) | Combined method for treating hormono-dependent disorders. | |
AU5787999A (en) | Method for treating neurodegenerative disorders | |
AU2001277938A1 (en) | Method for treating angina | |
AU2001276005A1 (en) | Method for treating a neoplasm | |
AU2002241670A1 (en) | Method for treating glaucoma IB | |
AU2002214487A1 (en) | Method for inducing apoptiosis | |
EP1389456A4 (en) | Method for cosmetic operation | |
AU2002325855A1 (en) | Method for reconditioning rollers | |
GB0026838D0 (en) | Treatment method | |
AU2002234589A1 (en) | Method for controlling id cards | |
AU2001243297A1 (en) | Method for treating or preventing depression | |
EP1359910A4 (en) | Method for treating glaucoma ii b |